New and Revised Pharmacy and Medical Coverage Policies Available

Coverage policies

Humana's medical and pharmacy coverage policies are based on evidence published in peer-reviewed medical literature, technology assessments obtained from independent medical research organizations, evidence-based consensus statements and evidence-based guidelines from nationally recognized professional health care organizations.

Information about medical and pharmacy coverage policies can be found at by selecting "Medical and Pharmacy Coverage Policies" under "Resources." Policies can be reviewed by name or revision date. Users also may search for a particular policy using the search box. More detailed information can be found by reviewing "How to Read a Medical Coverage Policy" and "Understanding the Medical Coverage Policy Development Process" under “Helpful Links.”

Below are new, revised and retired policies:

New pharmacy coverage policies

  • Briviact (brivaracetam)
  • Defitelio (defibrotide sodium)
  • Evomela (melphalan)
  • Nuplazid (pimavanserin)
  • Trintellix (vortioxetine)
  • Venclexta (venetoclax)

Revised pharmacy coverage policies

  • No policies with significant revisions

New medical coverage policies

  • Tilt table testing

Revised medical coverage policies

  • Cardiac monitoring devices
  • Cochlear implants, auditory brainstem implants
  • Genetic testing for diagnosis and monitoring – Noncancer indications
  • Reduction mammoplasty
  • Speech generating devices, voice prostheses

Retired medical coverage policies

  • No retired coverage policies